Aranesp
In the US, Aranesp (darbepoetin alfa systemic) is a member of the drug class recombinant human erythropoietins and is used to treat Anemia Associated with Chronic Renal Failure and Anemia - Chemotherapy Induced.
US matches:
UK matches:
Ingredient matches for Aranesp
Darbepoetin Alfa is reported as an ingredient of Aranesp in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Canada
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Ireland
- Israel
- Italy
- Latvia
- Lithuania
- Luxembourg
- Netherlands
- Norway
- Oman
- Poland
- Romania
- Russian Federation
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Turkey
- United Kingdom
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
